TP53 and medulloblastoma: WHO redefined pediatric medulloblastoma in 2021 into four subtypes: WNT, SHH-TP53 wild type, SHH-TP53 mutant type, and non-WNT/SHH type, incorporating the previous group3 and group4 types into the non-WNT/SHH type1.